NCT02628223View on ClinicalTrials.gov

180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma

NACompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Open Angle GlaucomaOcular HypertensionGlaucoma, Open Angle, Pseudo-exfoliativePigment Dispersion SyndromeGlaucoma
Interventions
PROCEDURE

Selective Laser Trabeculoplasty

The procedure uses light energy provided by a neodymium (Nd):Yttrium Aluminum Garnet (YAG) laser that is directed into the iridocorneal angle via a goniolens viewed through a standard slit lamp.

DEVICE

Neodymium:Yttrium Aluminum Garnet (YAG) laser

The procedure uses a 400 μm spot size of light energy provided by a low-energy, Q-switched, frequency-doubled (532 nm) neodymium (Nd):Yttrium Aluminum Garnet (YAG) laser with a short pulse duration of 3 nanoseconds that is directed into the iridocorneal angle via a goniolens viewed through a standard slit lamp.

Trial Locations (2)

19372

Levin Luminais Chronister Eye Associates, Thorndale

19810

Brandywine Eye Center, Wilmington

All Listed Sponsors
lead

Temple University

OTHER

NCT02628223 - 180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma | Biotech Hunter | Biotech Hunter